BioSpace News Archive

Adagene Inc. today announced appointment of an interim Chief Medical Officer and new members of its Scientific and Strategic Advisory Board (the “SAB”).

Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced second quarter 2021 financial results and recent business updates.

Lynk Pharmaceuticals Co., Ltd. , announced today that it has administered its triple-kinase inhibitor LNK01002 to the first patient in a phase I clinical trial.

Tenax Therapeutics, Inc. today announced a new publication that identifies a novel mechanism of action behind the improved cardiovascular hemodynamics and exercise tolerance that was reported in the recent Phase 2 HELP Study (Burkhoff et al., JACC Heart Failure 2021; 9:360-70).

Urovant Sciences, Inc. today announced the appointment of Betzy Estrada as executive vice president and chief human resources officer.

PhaseBio Pharmaceuticals, Inc. today announced that it has enrolled the first 143 patients in its pivotal Phase 3 REVERSE-IT trial for its lead product candidate bentracimab

Lone Star Pharmaceuticals, Inc. announced today it has joined the Council of Pharmacy Executives and Suppliers , also known as CPES, as a distinguished Corporate Member.

Biotricity , Inc. today announced that it will release its financial results for the first quarter of fiscal 2022, ended June 30, 2021, on Monday, August 16, 2021, after the close of the market.

Can-Fite BioPharma Ltd. today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of 5,000,000 of the Company’s American Depositary Shares

MiMedx Group, Inc. today announced the promotion of Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs.